AzurRx BioPharma, Inc.·4

Jul 20, 9:54 PM ET

Pennington James 4

4 · AzurRx BioPharma, Inc. · Filed Jul 20, 2020

Insider Transaction Report

Form 4
Period: 2020-07-16
Pennington James
CHIEF MEDICAL OFFICER
Transactions
  • Award

    Stock option (right to buy)

    2020-07-16+300,000300,000 total
    Exercise: $0.85Exp: 2030-07-15Common stock, par value $0.0001 per share (300,000 underlying)
Footnotes (1)
  • [F1]The stock option vests in 36 equal monthly installments over a term of three (3) years beginning on August 16, 2020, conditioned on Mr. Pennington's continued employment by AzurRx BioPharma, Inc. on the applicable vesting date.

Documents

1 file
  • 4
    form4-07202020_060736.xmlPrimary